Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 13

Contraception, Sexuality and Pregnancy in Women with Psoriasis: Real-Life Experience of 235 Women

Authors Maccari F, Fougerousse AC, Reguiai Z, Taieb C

Received 8 August 2020

Accepted for publication 7 October 2020

Published 11 November 2020 Volume 2020:13 Pages 817—823

DOI https://doi.org/10.2147/CCID.S275512

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Jeffrey Weinberg


François Maccari,1,2 Anne Claire Fougerousse,2,3 Ziad Reguiai,2,4 Charles Taieb5,6

1Private Practice, La Varenne St Hilaire, Paris, France; 2Reso Pso, Dermatologist Network, Paris, France; 3Military Teaching Hospital Bégin, Saint Mandé, Paris, France; 4Service De Dermatologie, Polyclinique Courlancy, Reims, France; 5FIMARAD, Hôpital Necker Enfants Malades, Paris, France; 6European Market Maintenance Assessment, Vincennes, Paris, France

Correspondence: Charles Taieb Email charles.taieb@emma.clinic

Background: Little is known about how women of childbearing age with psoriasis experience contraception, sexuality and pregnancies through the lens of their skin condition.
Objective: To evaluate the experiences and expectations in this group of patients.
Materials and Methods: In total, 235 women aged between 18 and 45 years old completed an online survey. We collected the characteristics of psoriasis, contraception and pregnancy history. Psoriasis severity was measured using the Simplified Psoriasis Index. Patient quality of life was assessed using the Dermatology Life Quality Index (DLQI) and the Short Form-12.
Results: Psoriasis was mild in 78% of cases. The mean DLQI score was 8.8, highlighting a moderate impact of psoriasis. In total, 28% of the women had no current follow-ups, while at least two distinct physicians followed 21% of these patients. In total, 31.5% of the women felt that they could discuss sexuality during their consultations. In addition, 63% of respondents had a contraceptive method, but more than half of the women reported that contraception was rarely or never discussed during the consultations. In total, 63% had at least one pregnancy, and 61.5% reported that the doctor managing their psoriasis did not discuss their pregnancy during consultations. Psoriasis worsened during pregnancy for 21% of the respondents but improved in 34%. Among women who were not pregnant, less than 15% reported that the doctor in charge of their psoriasis discussed family planning and pregnancy possibilities.
Conclusion: Our study shows that the management of women of childbearing age with psoriasis must be improved with respect to sexuality, contraception and pregnancy planning.

Keywords: psoriasis, women, childbearing

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]